Evidence map›Paper›PMID 34440011›Full record

ArticleBiology2021

Alcohol, Cannabis and Crossfading: Concerns for COVID-19 Disease Severity.

Vijay Sivaraman, Morgan M Richey, Abm Nasir

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vijay SivaramanDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC 27707, USA.ORCID 0000-0001-9848-6640
Morgan M RicheyDepartment of Epidemiology, Gillings School of Global Public Health, UNC Chapel Hill, Chapel Hill, NC 27514, USA.
Abm NasirBusiness School, North Carolina Central University, Durham, NC 27707, USA.
North Carolina Central University · USUniversity of North Carolina at Chapel Hill · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Understanding Perceptions of HIV Risk, PrEP, and PrEP use among African American Women Attending an HBCUU54MD012392 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI DEEPAK KUMAR · 2017 to 2026
$38.1M
Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory MediatorsSC2GM144188 · NIGMS · NORTH CAROLINA CENTRAL UNIVERSITY · PI SIVARAMAN, VIJAY · 2022 to 2024
$449k
NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1 TR002489NIEHS NIH HHS P30 ES025128NIGMS NIH HHS SC2 GM144188NIMHD NIH HHS U54 MD012392
6 · The paper itself

Abstract

Risk factors for severe COVID-19 pathology are currently being investigated worldwide. The emergence of this highly infectious respiratory disease has plagued the world, with varying severity across populations of different age, race, and socio-economic level. These data suggest that other environmental or social factors may contribute to this disease's severity. Using a mouse model, we identify heavy alcohol and cannabinoid consumption as risk factors for increased pulmonary pathology in the setting of exposure to a microbial pulmonary pathogen (

Indexed as

alcoholcannabisCOVID-19crossfadingpneumonia

Identifiers

PMID34440011
PMCPMC8389695
OpenAlexW3194064367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.